The two semi-finalists, Abreos and Immusoft, were in fact my two favourite contenders from the very beginning. Kamiskiy, finding himself at the center of the emerging consensus, commented " It was a challenging but extremely interesting duty to serve as a judge at the companies competition alongside such progressive yet well-respected firms as Illumina Ventures and DXdigital Ventures.
#MEDICAL CONFERENCES 2016 UK SERIES#
This year's panel was comprised of the managing director at the venture fund DigitalDx Ventures Ted Driscoll, the executive director of Breakout Labs Lindy Fishburne, Partner at Illumina Ventures Alexis Ji, the CEO of Genia Technologies Stefan Roever, and Biogerontology Research Foundation's managing trustee Dmitry Kaminskiy, also co-founder and Managing Partner of Deep Knowledge Ventures, whose inclusion on the panel reflected this year's unprecedented focus on the future role of artificial Intelligence in precision medicine.Īfter a series of presentations from companies and questions from judges and audience members, two semifinalists emerged: Abreos, a San Diego-based company developing laboratory-based and point-of-care assays for precision dose monitoring of biologic drugs and Immusoft, based in Seattle, who are currently developing of a platform for treating a variety of genetic diseases through a process called Immune System Programming (ISP™).
The event featured talks by many leading Longevity, AI and Precision Medicine companies, including Calico, 23andMe, Regeneron, Insilico Medicine, Atomwise, and many others.Ĭentral to proceedings was the competition for the PMWC 2018 Most Promising Company Award, in which a panel of judges attempted to identify future pioneers in precision medicine from among the new companies present. The event was co-hosted by Duke university, John Hopkins University, the University of Michigan, and the University of California.
To attendees it was an opportunity to learn first-hand about the latest advances in precision medicine: thriving initiatives and clinical case studies that enable the translation of precision medicine into direct improvements in health care.īut to developing and emerging startup companies in diagnostics, therapeutics, and health tech, it was a golden opportunity to increase their visibility by presenting themselves to a group of leading investors, potential clients and partners. The 13th installment of the Precision Medicine World Conference took place this year in Silicon Valley between January 22-24 at the Computer History Museum in Mountain View, CA. Tuesday, January 30, 2018, London, UK: The Biogerontology Research Foundation is pleased to announce the participation of Managing Trustee Dmitry Kaminskiy as a judge on the 2018 PMWC Most Promising Company competition at the Precision Medicine World Conference 2018.
0 kommentar(er)
